In spite of this, dose sales growth has been phenomenal, this half year excluded. At this price, if they grow at 3% dose sales a year and you factor in the operational leverage, the returns are great.
In spite of this, dose sales growth has been phenomenal, this...
-
- There are more pages in this discussion • 117 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
-0.003(1.41%) |
Mkt cap ! $75.62M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.8¢ | 17.5¢ | $4.968K | 28.32K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 5792335 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 265720 | 27 |
View Market Depth
| Last trade - 15.20pm 30/09/2024 (20 minute delay) ? |
| SRX (ASX) Chart |